首页> 美国卫生研究院文献>The Journal of Clinical Endocrinology and Metabolism >The Role of Glutamic or Aspartic Acid in Position Four of the Epitope Binding Motif and Thyrotropin Receptor-Extracellular Domain Epitope Selection in Graves Disease
【2h】

The Role of Glutamic or Aspartic Acid in Position Four of the Epitope Binding Motif and Thyrotropin Receptor-Extracellular Domain Epitope Selection in Graves Disease

机译:谷氨酸或天冬氨酸在表位结合基序的第四位和促甲状腺素受体-细胞外结构域表位选择在格雷夫斯病中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Context: Development of Graves' disease (GD) is related to HLA-DRB1*0301 (DR3),and more specifically to arginine at position 74 of the DRB1 molecule. The extracellular domain (ECD) of human TSH receptor (hTSH-R) contains the target antigen.>Objective and Design: We analyzed the relation between hTSH-R-ECD peptides and DR molecules to determine whether aspartic acid (D) or glutamic acid (E) at position four in the binding motif influenced selection of functional epitopes.>Results: Peptide epitopes from TSH-R-ECD with D or E in position four (D/E+) had higher affinity for binding to DR3 than peptides without D/E (D/E−) (IC50 29.3 vs. 61.4, P = 0.0024). HLA-DR7, negatively correlated with GD, and DRB1*0302 (HLA-DR18), not associated with GD, had different profiles of epitope binding. Toxic GD patients who are DR3+ had higher responses to D/E+ peptides than D/E− peptides (stimulation index 1.42 vs. 1.22, P = 0.028). All DR3+ GD patients (toxic + euthyroid) had higher responses, with borderline significance (Sl; 1.32 vs. 1.18, P = 0.051). Splenocytes of DR3 transgenic mice immunized to TSH-R-ECD responded to D/E+ peptides more than D/E− peptides (stimulation index 1.95 vs. 1.69, P = 0.036). Seven of nine hTSH-R-ECD peptide epitopes reported to be reactive with GD patients' peripheral blood mononuclear cells contain binding motifs with D/E at position four.>Conclusions: TSH-R-ECD epitopes with D/E in position four of the binding motif bind more strongly to DRB1*0301 than epitopes that are D/E− and are more stimulatory to GD patients' peripheral blood mononuclear cells and to splenocytes from mice immunized to hTSH-R. These epitopes appear important in immunogenicity to TSH-R due to their favored binding to HLA-DR3, thus increasing presentation to T cells.
机译:>背景:格雷夫斯病(GD)的发展与HLA-DRB1 * 0301(DR3)有关,更具体而言,与DRB1分子第74位的精氨酸有关。人TSH受体(hTSH-R)的胞外域(ECD)包含目标抗原。>目的和设计:我们分析了hTSH-R-ECD肽与DR分子之间的关系,以确定天冬氨酸是否存在结合基序中第4位的(D)或谷氨酸(E)影响功能性表位的选择。>结果: TSH-R-ECD的肽表位,其中D或E在第4位(D / E + )比不具有D / E(D / E-)的肽具有更高的结合DR3的亲和力(IC50 29.3 vs.61.4,P = 0.0024)。与GD负相关的HLA-DR7和与GD不相关的DRB1 * 0302(HLA-DR18)具有不同的表位结合特征。 DR3 +的有毒GD患者对D / E +肽的反应比D / E-肽高(刺激指数1.42对1.22,P = 0.028)。所有DR3 + GD患者(毒性+甲状腺功能正常)均具有较高的反应,具有临界意义(S1; 1.32 vs. 1.18,P = 0.051)。用TSH-R-ECD免疫的DR3转基因小鼠的脾细胞对D / E +肽的反应比对D / E-肽的反应更多(刺激指数1.95对1.69,P = 0.036)。据报道,与GD患者外周血单核细胞有反应的9个hTSH-R-ECD肽表位中有7个在第4位具有D / E结合基序。>结论: TSH-R-ECD带有D的表位与D / E-的表位相比,结合基序第4位的/ E与DRB1 * 0301的结合更牢固,对GD患者的外周血单核细胞和免疫hTSH-R的小鼠的脾细胞更具刺激性。这些表位由于对HLA-DR3的有利结合而在针对TSH-R的免疫原性中显得很重要,因此增加了对T细胞的呈递。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号